Control Bionics Ltd. ( (AU:CBL) ) just unveiled an announcement.
Control Bionics Ltd. announced the cessation of Peter Ford as a director effective March 31, 2025. Ford held a significant number of ordinary shares, totaling 20,003,433, which may influence the company’s shareholder dynamics. This change in directorship could impact the company’s strategic direction and governance, potentially affecting stakeholders’ interests.
More about Control Bionics Ltd.
Control Bionics Ltd. operates in the technology sector, focusing on developing innovative communication and control solutions for individuals with disabilities. The company is known for its assistive technology products that enhance the quality of life for people with severe disabilities, enabling them to communicate and interact with their environment.
YTD Price Performance: -25.00%
Average Trading Volume: 168,832
Technical Sentiment Signal: Buy
Current Market Cap: A$11.49M
For an in-depth examination of CBL stock, go to TipRanks’ Stock Analysis page.